Ray Dalio
SNV

Ray Dalio’s Synovus SNV Stock Holding History

Ray Dalio’s Portfolio SNV Stock Details SNV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-54,509
Closed -$2.73M – 1202
2025
Q4 		$2.73M Sell
54,509
-189,496
-78% -$9.11M 0.01% 699
2025
Q3 		$12M Buy
+244,005
New +$12.5M 0.05% 303
2025
Q2 		– Sell
-9,662
Closed -$452K – 714
2025
Q1 		$452K Sell
9,662
-52,913
-85% -$2.73M ﹤0.01% 574
2024
Q4 		$3.21M Buy
+62,575
New +$3.24M 0.01% 405
2023
Q1 		– Sell
-53,052
Closed -$1.99M – 877
2022
Q4 		$1.99M Buy
53,052
+17,677
+50% +$702K 0.01% 533
2022
Q3 		$1.33M Buy
35,375
+23,822
+206% +$945K 0.01% 645
2022
Q2 		$416K Sell
11,553
-3,947
-25% -$163K ﹤0.01% 914
2022
Q1 		$760K Sell
15,500
-10,460
-40% -$530K ﹤0.01% 837
2021
Q4 		$1.24M Sell
25,960
-31,371
-55% -$1.49M 0.01% 535
2021
Q3 		$2.52M Buy
57,331
+11,834
+26% +$500K 0.01% 402
2021
Q2 		$2M Buy
45,497
+1,099
+2% +$51.6K 0.01% 485
2021
Q1 		$2.03M Buy
44,398
+21,758
+96% +$911K 0.02% 277
2020
Q4 		$733K Buy
+22,640
New +$655K 0.01% 423
2020
Q1 		– Sell
-30,503
Closed -$1.2M – 573
2019
Q4 		$1.2M Buy
+30,503
New +$1.12M 0.01% 292

Other funds holding SNV

WBWA
William B. Walkup & Associates Columbia, South Carolina $208M AUM 37.34% 1-Year Est. Return

Ray Dalio's SNV Position: Q1 2026 in Review

Ray Dalio sold out of Synovus (SNV) in Q1 2026, closing a stake of 54,509 shares — an estimated $2.73M sold.

Ray Dalio first reported a position in SNV in Q4 2019 and held it in 14 quarters. The position peaked at $12M in Q3 2025. 1 fund tracked by Wall St. Rank holds SNV as of Q1 2026.

  • Ray Dalio reported no remaining Synovus position as of Q1 2026 after selling out during the quarter.
  • Ray Dalio sold 54,509 Synovus shares in Q1 2026, an estimated $2.73M.
  • Ray Dalio first reported a position in Synovus in Q4 2019 and held it in 14 quarters.
  • Ray Dalio's Synovus position peaked at $12M in Q3 2025.
  • 1 fund tracked by Wall St. Rank held Synovus as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.